Loading clinical trials...
Loading clinical trials...
Golimumab Effect in the Modulation of Gut Microbiota in Ulcerative Colitis: Pilot Study
Conditions
Interventions
Golimumab
Locations
1
Spain
Hospital Doctor Josep Trueta
Girona, Catalonia, Spain
Start Date
October 1, 2016
Primary Completion Date
March 1, 2020
Completion Date
October 1, 2020
Last Updated
July 19, 2021
NCT07271069
NCT06975722
NCT07185009
NCT07184996
NCT07245394
NCT07089420
Lead Sponsor
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions